日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.

对一系列患者来源的异种移植瘤和细胞系进行基因组分析,发现伊沙匹隆是一种对抗化疗耐药性骨肉瘤的有效药物

Manara Maria Cristina, Bruzzese Francesca, Formentini Laura, Landuzzi Lorena, Pazzaglia Laura, Laginestra Maria Antonella, Carrabotta Marianna, Roca Maria Serena, Iannelli Federica, Grumetti Laura, Addi Laura, Parra Alessandro, Cristalli Camilla, Pasello Michela, Bavelloni Alberto, Carreras Francesca, Ruzzi Francesca, Bianchi Giuseppe, Gambarotti Marco, Righi Alberto, Budillon Alfredo, Lollini Pier-Luigi, Scotlandi Katia

Dexpramipexole improves bioenergetics and outcome in experimental stroke

右普拉米克索可改善实验性卒中的生物能量学和预后

Muzzi, Mirko; Gerace, Elisabetta; Buonvicino, Daniela; Coppi, Elisabetta; Resta, Francesco; Formentini, Laura; Zecchi, Riccardo; Tigli, Laura; Guasti, Daniele; Ferri, Martina; Camaioni, Emidio; Masi, Alessio; Pellegrini-Giampietro, Domenico E; Mannaioni, Guido; Bani, Daniele; Pugliese, Anna M; Chiarugi, Alberto

In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning

体内抑制神经元线粒体H+-ATP合酶可促进代谢预适应

Formentini, Laura; Pereira, Marta P; Sánchez-Cenizo, Laura; Santacatterina, Fulvio; Lucas, José J; Navarro, Carmen; Martínez-Serrano, Alberto; Cuezva, José M

Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype

人类肿瘤中线粒体H+-ATP合酶的ATPase抑制因子1 (IF1) 的上调介导癌细胞向Warburg表型的代谢转变

Sánchez-Cenizo, Laura; Formentini, Laura; Aldea, Marcos; Ortega, Alvaro D; García-Huerta, Paula; Sánchez-Aragó, María; Cuezva, José M